Vaccine Therapy in Treating Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Vaccines made from a person's tumor cells may make the body build an immune
response and kill their tumor cells. Peripheral stem cell transplantation may be able to
replace immune cells that were destroyed by chemotherapy used to kill tumor cells.
PURPOSE: Phase II trial to study the effectiveness of peripheral stem cell transplantation
plus vaccine therapy and chemotherapy in treating patients who have multiple myeloma.